Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-ethyl-6-methyl-3-hydroxypyridine Succinate
2. 3-pyridinol, 2-ethyl-6-methyl-, Butanedioate (1:1) (salt)
3. Butanedioic Acid, Compd. With 2-ethyl-6-methyl-3-pyridinol (1:1)
4. Emoxypine Succinate
5. Methylethylpiridinol Succinate
6. Mexiprim
1. 127464-43-1
2. 2-ethyl-6-methylpyridin-3-ol Succinate
3. Emoxypine Succinate
4. 2-ethyl-3-hydroxy-6-methylpyridine Succinate
5. Emoxypine (succinate)
6. Butanedioic Acid, Compd. With 2-ethyl-6-methyl-3-pyridinol (1:1)
7. 2r985002ct
8. 2-ethyl-6-methyl-3-pyridinol Succinate (salt)
9. Mexiprim
10. Emicidine
11. 2-ethyl-6-methyl-3-hydroxypyridine Succinate
12. Methylethylpiridinol Succinate
13. 2-ethyl-6-methyl-3-pyridinol Succinate
14. Unii-2r985002ct
15. Emicidin
16. Mexicor
17. Cambridge Id 5110148
18. Schembl1010987
19. Dtxsid30155577
20. 3-pyridinol, 2-ethyl-6-methyl-, Butanedioate (1:1) (salt)
21. Bcp13396
22. Hy-w002620a
23. Mfcd00445612
24. Akos003239209
25. 2-ethyl-6-methylpyridin-3-olsuccinate
26. Ds-13730
27. Cs-0182823
28. E1069
29. Ft-0660570
30. Butanedioic Acid;2-ethyl-6-methylpyridin-3-ol
31. Methylethylpiridinol Succinate [who-dd]
32. T71674
33. 647m960
34. A805706
35. Q-100116
36. Q27255507
Molecular Weight | 255.27 g/mol |
---|---|
Molecular Formula | C12H17NO5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 255.11067264 g/mol |
Monoisotopic Mass | 255.11067264 g/mol |
Topological Polar Surface Area | 108 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 198 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Psychotropic Drugs
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
ABOUT THIS PAGE
A Emoxypine Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emoxypine Succinate, including repackagers and relabelers. The FDA regulates Emoxypine Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emoxypine Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Emoxypine Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Emoxypine Succinate supplier is an individual or a company that provides Emoxypine Succinate active pharmaceutical ingredient (API) or Emoxypine Succinate finished formulations upon request. The Emoxypine Succinate suppliers may include Emoxypine Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Emoxypine Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Emoxypine Succinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Emoxypine Succinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Emoxypine Succinate GMP manufacturer or Emoxypine Succinate GMP API supplier for your needs.
A Emoxypine Succinate CoA (Certificate of Analysis) is a formal document that attests to Emoxypine Succinate's compliance with Emoxypine Succinate specifications and serves as a tool for batch-level quality control.
Emoxypine Succinate CoA mostly includes findings from lab analyses of a specific batch. For each Emoxypine Succinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Emoxypine Succinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Emoxypine Succinate EP), Emoxypine Succinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Emoxypine Succinate USP).
LOOKING FOR A SUPPLIER?